Showing results (231-240 of 317) with videos related to

Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Critical Reviews in Oncology/Hematology|February 11, 2015
Pooled analysis of the surgical treatment for colorectal cancer liver metastasesG Veereman, J Robays, L Verleye, et al.
British Journal of Cancer|May 10, 2012
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cellsT Troiani, L Vecchione, E Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2014
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trialE Élez, I Kocáková, T Höhler, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2020
Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 studyE Van Cutsem, K Muro, D Cunningham, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillanceS Laurent, D Franchimont, J P Coppens, et al.
ESMO Open|December 20, 2023
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 studyJ Ajani, F El Hajbi, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalT Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancerM M Eatock, N C Tebbutt, C L Bampton, et al.
ESMO Open|August 15, 2024
Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trialsF Lordick, E Van Cutsem, K Shitara, et al.
Pageof 32